1. Home
  2. TKNO vs HCAT Comparison

TKNO vs HCAT Comparison

Compare TKNO & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

N/A

Current Price

$2.67

Market Cap

138.1M

Sector

Health Care

ML Signal

N/A

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

N/A

Current Price

$1.79

Market Cap

121.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TKNO
HCAT
Founded
1996
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
138.1M
121.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
TKNO
HCAT
Price
$2.67
$1.79
Analyst Decision
Hold
Analyst Count
0
10
Target Price
N/A
$4.06
AVG Volume (30 Days)
171.5K
974.8K
Earning Date
06-03-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
43.86
44.98
EPS
N/A
N/A
Revenue
$40,520,000.00
$306,584,000.00
Revenue This Year
$8.65
$3.30
Revenue Next Year
$13.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.35
3.60
52 Week Low
$1.91
$1.56
52 Week High
$7.48
$5.06

Technical Indicators

Market Signals
Indicator
TKNO
HCAT
Relative Strength Index (RSI) 57.36 42.83
Support Level N/A $1.62
Resistance Level $5.39 $2.45
Average True Range (ATR) 0.21 0.14
MACD 0.11 0.02
Stochastic Oscillator 86.70 49.43

Price Performance

Historical Comparison
TKNO
HCAT

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: